Top holdings
43.98%Per cent of portfolio in top holdings
| Holding | % of portfolio |
|---|---|
| Eli Lilly and Co | 8.05% |
| Roche Holding AG | 6.49% |
| AstraZeneca PLC | 5.28% |
| Thermo Fisher Scientific Inc | 4.65% |
| Teva Pharmaceutical Industries Ltd ADR | 3.92% |
| CVS Health Corp | 3.79% |
| UCB SA | 3.33% |
| Genmab AS | 2.98% |
| Chugai Pharmaceutical Co Ltd | 2.75% |
| H. Lundbeck AS Ordinary Shares - Class B | 2.74% |
As of Dec 31 2025. Top holdings excludes cash and cash equivalents.
Sector weighting
| Sector | % of portfolio |
|---|---|
| Healthcare | 99.63% |
As of Dec 31 2025.
Regional holdings
| Holding | % of portfolio |
|---|---|
| USA | 49.06% |
| Switzerland | 11.54% |
| UK | 9.64% |
| Denmark | 9.45% |
| Germany | 4.10% |
| Israel | 3.92% |
| Japan | 3.63% |
| Belgium | 3.33% |
| India | 2.19% |
| Other | 2.76% |
As of Dec 31 2025.
